About the Marsha Rivkin Center - Ovarian Cancer Screening Program

Ovarian Cancer Screening Program

The average woman diagnosed with ovarian cancer is only expected to live for 3 - 4 years after completing treatment. In contrast, survival for localized ovarian cancer is about 90%, suggesting that earlier detection would result in significant mortality reduction. The Marsha Rivkin Center is working aggressively to improve these statistics through our pilot study program and by providing screening for average and high-risk women. Screening is provided in partnership with cutting-edge scientific research programs. Until a cure is found, early detection is our best defense.

Screening studies partially funded by the Marsha Rivkin Center:

Ovarian Cancer Early Detection Study

(Recruitment & Study Open)

The Ovarian Cancer Early Detection Study is designed to use ovarian ultrasound and CA 125 testing to improve early detection of ovarian cancer in women at increased risk. The Marsha Rivkin Center provides screening to all participants in the Seattle area.

Please contact the Marsha Rivkin Center for more information about participating in this study.

Quality of Life Effects of Ovarian Cancer Screening and Risk Education (QUEST)

(Recruitment & Study Closed)

The QUEST study was designed to test the effect on quality of life of an intensive screening program and risk counseling, individually and in combination, compared with standard care. The Marsha Rivkin Center provided CA 125 and ovarian ultrasound screening to randomized average-risk participants.